KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,000 | -96.8% | 171 | -96.5% | 0.00% | -100.0% |
| Q1 2020 | $94,000 | +108.9% | 4,841 | +105.5% | 0.01% | +133.3% |
| Q4 2019 | $45,000 | +2150.0% | 2,356 | +857.7% | 0.00% | – |
| Q3 2019 | $2,000 | -99.8% | 246 | +347.3% | 0.00% | – |
| Q2 2018 | $934,000 | +93300.0% | 55 | -31.2% | 0.00% | – |
| Q1 2018 | $1,000 | -80.0% | 80 | -77.3% | 0.00% | – |
| Q1 2017 | $5,000 | -61.5% | 352 | -74.2% | 0.00% | -100.0% |
| Q4 2016 | $13,000 | – | 1,366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |